Table 2:
Association testing for all salivary gland AdCCs for lymph node dissection with tumor stage, gender, and overall survival (OS).
| Lymph node dissection | No (0 nodes) N=18 |
Limited (1–3 nodes) N=41 |
Yes (>3 nodes) N=12 |
Unknown N=1 |
P-value |
|---|---|---|---|---|---|
| AJCC Tumor Stage | |||||
| 1 | 5 (27.8%) | 10 (24.4%) | 3 (25.0%) | 0 (0%) | 0.0514 |
| 2 | 3 (16.7%) | 16 (39.0%) | 3 (25.0%) | 1 (100%) | |
| 3 | 3 (16.7%) | 9 (22.0%) | 0 (0%) | 0 (0%) | |
| 4 | 4 (22.2%) | 3 (7.3%) | 6 (50.0%) | 0 (0%) | |
| Unknown | 3 (16.7%) | 3 (7.3%) | 0 (0%) | 0 (0%) | |
| Gender | |||||
| Female | 7 (38.9%) | 31 (75.6%) | 8 (66.7%) | 0 (0%) | 0.0198 |
| Male | 11 (61.1%) | 10 (24.4%) | 4 (33.3%) | 1 (100%) | |
| Overall Survival | |||||
| Alive | 13 (72.2%) | 39 (95.1%) | 11 (91.7%) | 1 (100%) | 0.022 |
| Dead | 5 (27.8%) | 1 (2.4%) | 1 (8.3%) | 0 (0%) | |
| Missing | 0 (0%) | 1 (2.4%) | 0 (0%) | 0 (0%) |